Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Cannabidiol Extract Market Size & Growth Forecast 2027–2036, By Segments (Application, Type, Source), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 21528| Published Date: Jun-2026| Format: PDF, Excel
MARKET OUTLOOK

Market Size and Growoth Outlook

Cannabidiol Extract Market size was more than USD 9.84 Billion in 2026 and is set to grow at 21.42% CAGR between 2027 and 2036, attaining USD 68.53 Billion by 2036. The industry revenue for 2027 is calculated at USD 11.7 Billion.

Base Year Value (2026)
USD 9.84 Billion
CAGR (2027-2036)
21.42%
Forecast Year Value (2036)
USD 68.53 Billion
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
SNAPSHOT

Cannabidiol Extract Market Intelligence Snapshot

Regional Market Dynamics

  • North America led through growing consumer awareness, broader cannabidiol applications, specialized extraction capabilities, and expanding demand for wellness and personal care formulations.
  • Asia Pacific is projected to grow fastest as awareness, disposable incomes, e-commerce access, processing investment, and regulatory development increasingly support cannabidiol product adoption.

Segment Momentum

  • Pharmaceutical applications accounted for 62.33% share in 2026, supported by therapeutic formulations, clinical interest, and rising acceptance of cannabinoid-based treatments.
  • The cosmetics segment is growing fastest as skincare and personal care manufacturers incorporate cannabidiol extracts into multifunctional wellness and beauty formulations.

Market Expansion Drivers

  • Expanding medical applications of cannabidiol driving clinical adoption across chronic pain and neurological disorders
  • Evolving regulatory approvals enabling wider commercialization of CBD-based pharmaceutical and wellness products
  • Rising consumer preference for plant-based therapeutic extracts supporting broader CBD product penetration

Leading Market Participants

  • Top players in the cannabidiol extract market include Aurora Cannabis Inc. (Canada), Tilray Brands, Inc. (Canada), Canopy Growth Corporation (Canada), Cronos Group Inc. (Canada), Charlotte’s Web Holdings, Inc. (United States), Curaleaf Holdings, Inc. (United States), Green Roads (United States), Mile High Labs International Inc. (United States), Folium Biosciences (United States), NuLeaf Naturals LLC (United States)

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 9.84 Billion
  • 2027 Estimated Market Size: USD 11.7 Billion
  • Projected Market Size: USD 68.53 Billion by 2036
  • Growth Forecast: 21.42% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Pharmaceutical (Application) | CBD Isolates (Type) | Marijuana (Source)
  • Emerging Opportunity Segment: Cosmetics (Application) | CBD Oil Extracts (Type) | Hemp (Source)
MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Expanding medical applications of cannabidiol driving clinical adoption across chronic pain and neurological disorders

The expanding use of cannabidiol in therapeutic care is strengthening its position within modern treatment approaches, and the cannabidiol extract market is benefiting from growing clinical interest in managing chronic pain and neurological disorders. Healthcare providers and researchers are evaluating cannabidiol-based formulations for their potential to address complex conditions while offering alternative treatment options for patients who may require long-term symptom management. Continued integration of cannabidiol into clinical research and specialized healthcare settings is encouraging pharmaceutical development, improved formulation strategies, and broader acceptance of cannabinoid-based therapies across diverse medical applications.

Evolving regulatory approvals enabling wider commercialization of CBD-based pharmaceutical and wellness products

Progressive regulatory developments are creating a more favorable environment for the introduction of cannabidiol-based products across pharmaceutical and wellness segments. This shift will drive the cannabidiol extract market growth as manufacturers gain clearer pathways for product development, commercialization, and distribution while complying with evolving quality and safety standards. Greater regulatory clarity encourages investment in product innovation, standardized manufacturing practices, and clinical validation, enabling companies to expand portfolios that address both therapeutic and consumer wellness applications.

Rising consumer preference for plant-based therapeutic extracts supporting broader CBD product penetration

Consumer interest in naturally derived health solutions is reshaping purchasing behavior across the wellness industry, creating favorable conditions for the cannabidiol extract market as plant-based therapeutic extracts gain wider acceptance. Individuals are increasingly seeking botanical products that align with holistic health preferences and wellness-focused lifestyles, encouraging manufacturers to diversify cannabidiol offerings across multiple delivery formats. This trend is also supporting the development of premium formulations that emphasize ingredient transparency, quality assurance, and naturally sourced components to meet evolving consumer expectations.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Expanding medical applications of cannabidiol driving clinical adoption across chronic pain and neurological disorders 3.1% High North America, Europe High Near Term
Evolving regulatory approvals enabling wider commercialization of CBD-based pharmaceutical and wellness products 2.8% High North America, Europe, Latin America High Near Term
Rising consumer preference for plant-based therapeutic extracts supporting broader CBD product penetration 2.4% Moderate North America, Asia Pacific, Europe High Mid Term
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
Largest Market Share in 2026

North America (Largest Region)

North America dominated the cannabidiol extract market in 2026, benefiting from growing consumer awareness of cannabidiol-based products, expanding applications across wellness and personal care categories, and an increasingly developed market ecosystem. The region has experienced broader acceptance of cannabidiol ingredients in consumer products, supported by growing interest in plant-derived alternatives and changing preferences toward natural wellness solutions. Demand is also being encouraged by the expanding use of cannabidiol extracts in functional formulations and topical products. In addition, the development of specialized processing and extraction capabilities is supporting product innovation and improving the availability of cannabidiol-based formulations. Continued consumer interest in wellness-oriented products and evolving regulatory frameworks are expected to support further market development.

Asia Pacific (Fastest-Growing Region)

Asia Pacific is projected to experience the fastest growth, supported by increasing awareness of cannabidiol-derived products, expanding wellness markets, and growing interest in botanical ingredients. Rising disposable incomes and changing consumer preferences are encouraging demand for natural and plant-based products across personal care, wellness, and other emerging applications. Improvements in retail and e-commerce infrastructure are also making specialized cannabidiol products more accessible to consumers. Furthermore, increasing investment in processing capabilities and gradual development of regulatory frameworks for cannabinoid-derived products are creating a more favorable environment for market expansion. As awareness and acceptance continue to develop across the region, opportunities for cannabidiol extracts are expected to broaden.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

United States 🇺🇸

Product Innovation Hub

The U.S. cannabidiol extract market emphasizes product diversification across wellness, personal care, and nutraceutical applications. Companies prioritize quality assurance, standardized extraction processes, and transparent sourcing to address evolving consumer and regulatory expectations.

Germany 🇩🇪

Pharmaceutical Quality Standards

Germany focuses on cannabidiol extracts manufactured with stringent quality controls and traceable production practices. Demand is concentrated on applications requiring reliable formulation consistency and compliance with established regulatory and healthcare standards.

Japan 🇯🇵

Controlled Wellness Expansion

Japan approaches cannabidiol extract development with careful emphasis on product quality, ingredient verification, and regulatory alignment. Market participants prioritize premium formulations and consumer confidence through transparent manufacturing and testing practices.

South Korea 🇰🇷

Premium Ingredient Development

South Korea explores cannabidiol extract opportunities through innovation in cosmetics, wellness, and specialty consumer products where regulations permit. Companies emphasize high-purity extracts, formulation research, and product differentiation for value-added applications.

France 🇫🇷

Natural Wellness Applications

France emphasizes cannabidiol extracts for wellness and personal care products supported by quality-focused manufacturing. Businesses invest in refined extraction technologies and consistent ingredient standards to strengthen product credibility and commercial acceptance.

Italy 🇮🇹

Botanical Extract Processing

Italy supports cannabidiol extract development through expertise in botanical ingredient processing and premium wellness products. Manufacturers prioritize standardized extraction methods and dependable supply chains to serve evolving consumer and commercial application needs.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Cannabidiol Extract Market Share (%), Type, 2026

CBD oil extracts
CBD isolates

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Application Segment Analysis: Pharmaceutical (Largest Segment) vs Cosmetics (Fastest-Growing Segment)

The pharmaceutical segment dominated the cannabidiol extract market, accounting for 62.33% of the market share in 2026. Its leadership is supported by the increasing use of cannabidiol extracts in therapeutic formulations and the growing emphasis on developing products that address a range of medical conditions. Continued investment in pharmaceutical research, expanding clinical interest, and rising acceptance of cannabinoid-based therapies have strengthened demand for pharmaceutical-grade cannabidiol extracts.

The cosmetics segment is the fastest-growing application as manufacturers increasingly incorporate cannabidiol extracts into skincare, personal care, and wellness products. Growing consumer preference for multifunctional ingredients, coupled with rising interest in formulations associated with skin conditioning and premium beauty products, is driving wider adoption across the cosmetics industry.

Type Segment Analysis: CBD Isolates (Largest Segment) vs CBD Oil Extracts (Fastest-Growing Segment)

CBD isolates held the largest position in the type segment in 2026. Their high purity, precise formulation capabilities, and suitability for applications requiring controlled cannabidiol content have made them a preferred choice across several industries. Manufacturers also value CBD isolates for their consistency, ease of incorporation into finished products, and ability to meet specific product formulation requirements.

The cannabidiol extract market is experiencing the fastest growth in the CBD oil extracts segment as demand rises for products containing a broader range of naturally occurring plant compounds. Consumer interest in minimally processed extracts and expanding product availability across wellness and personal care categories are contributing to stronger adoption of CBD oil extracts.

Source Segment Analysis: Marijuana (Largest Segment) vs Hemp (Fastest-Growing Segment)

Marijuana was the dominant source segment in 2026, holding the largest share of the market. Its leadership is supported by its established role in producing cannabidiol extracts for applications where higher cannabinoid content and specialized product formulations are required. Ongoing product development and expanding commercial availability in regulated markets continue to reinforce the segment's position.

In the cannabidiol extract market, the hemp segment is emerging as the fastest-growing source due to expanding cultivation, evolving regulatory acceptance in numerous regions, and increasing demand for hemp-derived cannabidiol products. Manufacturers are also benefiting from broader consumer acceptance of hemp-based formulations, supporting the segment's continued expansion across pharmaceutical, wellness, and consumer product applications.

Segment Sub-Segment Largest Segment Fastest Growing
Application Pharmaceutical, Food & Beverages, Cosmetics, Others Pharmaceutical Cosmetics
Type CBD Oil Extracts, CBD Isolates CBD Isolates CBD Oil Extracts
Source Hemp, Marijuana Marijuana Hemp
Competitive Landscape

Competitive Landscape and Market Positioning

Prominent players in the cannabidiol extract market:

  1. Aurora Cannabis, Inc. (Canada)
  2. Tilray Brands, Inc. (Canada)
  3. Canopy Growth Corporation (Canada)
  4. Cronos Group, Inc. (Canada)
  5. Charlotte’s Web Holdings, Inc. (United States)
  6. Curaleaf Holdings, Inc. (United States)
  7. Green Roads (United States)
  8. Mile High Labs International, Inc. (United States)
  9. Folium Biosciences (United States)
  10. NuLeaf Naturals LLC (United States)

The cannabidiol extract market is seeing competition move toward product differentiation, quality assurance, and the ability to navigate evolving regulatory expectations. Producers are increasingly focused on refining extraction capabilities, improving consistency, and developing specialized formulations that address diverse end-use requirements. As the market matures, competitive advantage is shifting away from basic ingredient availability toward stronger control over sourcing, processing standards, and compliance practices that influence customer confidence and market access.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
Aurora Cannabis Inc. (Canada)
Tilray Brands Inc. (Canada)
Canopy Growth Corporation (Canada)
Cronos Group Inc. (Canada)
Charlotte’s Web Holdings Inc. (United States)
Curaleaf Holdings Inc. (United States)
Green Roads (United States)
Mile High Labs International Inc. (United States)
Folium Biosciences (United States)
NuLeaf Naturals LLC (United States)
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Vireo Growth Inc. Dec-24 Vireo Growth Inc. announced a USD 397 million merger with Proper Brands and three other cannabis companies. This strategic combination significantly expands its commercial and operational footprint across multiple states, including Missouri, Nevada, and Utah.
Charlotte's Web Dec-24 Charlotte's Web released positive updates on DeFloria's Phase 1 clinical trial results for AJA001, a multi-compound hemp extract intended for the treatment of autism spectrum disorder, demonstrating favorable safety and tolerability profiles.
Report Customization

Explore This Report

Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.

1 report.custom report.segments 2 Custom TOC 3 Related Reports

Cannabidiol Extract Market — Custom Segments

Segment Sub-Segment
Extraction Method Solvent Extraction, Supercritical CO₂ Extraction, Ethanol Extraction, Hydrocarbon Extraction
Product Form Oils and Tinctures, Concentrates and Resins, Capsules and Softgels, Powders
Distribution Channel Direct Sales, Specialty Retail, Pharmacies and Drugstores, E-commerce

Cannabidiol Extract Market — report.custom

Custom Chapter Custom Details
Regulatory Market Access Roadmap
  • Regulatory Requirements by Application
  • Market Access Readiness
  • Compliance and Documentation Priorities
  • Regulatory Uncertainty and Commercial Risk
  • Entry Sequencing and Market Access Priorities
Formulation & Brand Adoption Landscape
  • Formulation Development Priorities
  • Brand Adoption Drivers
  • Product Integration and Differentiation Opportunities
  • Consumer-Oriented Product Requirements
  • Commercialization Pathways
Quality Standardization Priorities
  • Quality Specification Frameworks
  • Testing and Analytical Requirements
  • Batch Consistency and Traceability
  • Standardization Gaps Across the Supply Ecosystem
  • Quality Assurance Priorities

Need a different cut of the data?

Request Custom Research
report.faq_name

What is the market size of cannabidiol extract?

The market size of the cannabidiol extract is estimated at USD 11.7 Billion in 2027.

How is the cannabidiol extract industry expected to grow over the next 10 years?

Cannabidiol Extract Market size was more than USD 9.84 Billion in 2026 and is set to grow at 21.42% CAGR between 2027 and 2036, attaining USD 68.53 Billion by 2036.

How are medical applications accelerating cannabidiol product commercialization?

Expanding clinical interest in chronic pain and neurological disorder applications is encouraging pharmaceutical development and improved cannabidiol formulations. Healthcare adoption is supporting broader acceptance and investment in specialized therapeutic products.

How is regulatory evolution influencing CBD market expansion strategies?

Clearer regulatory pathways are enabling manufacturers to improve product development, quality standards, and distribution strategies. Companies are investing in compliant formulations that address pharmaceutical and wellness market opportunities.

Why does the pharmaceutical segment lead the cannabidiol extract market?

Pharmaceutical applications accounted for 62.33% share in 2026, supported by therapeutic formulations, clinical interest, and rising acceptance of cannabinoid-based treatments.

How are cosmetics applications increasing cannabidiol extract adoption?

The cosmetics segment is growing fastest as skincare and personal care manufacturers incorporate cannabidiol extracts into multifunctional wellness and beauty formulations.

Why did North America lead the cannabidiol extract market in 2026?

North America led through growing consumer awareness, broader cannabidiol applications, specialized extraction capabilities, and expanding demand for wellness and personal care formulations.

How is Asia Pacific expected to drive future cannabidiol extract market growth?

Asia Pacific is projected to grow fastest as awareness, disposable incomes, e-commerce access, processing investment, and regulatory development increasingly support cannabidiol product adoption.

Which organizations are considered leaders in the cannabidiol extract landscape?

Top players in the cannabidiol extract market include Aurora Cannabis Inc. (Canada), Tilray Brands, Inc. (Canada), Canopy Growth Corporation (Canada), Cronos Group Inc. (Canada), Charlotte’s Web Holdings, Inc. (United States), Curaleaf Holdings, Inc. (United States), Green Roads (United States), Mile High Labs International Inc. (United States), Folium Biosciences (United States), NuLeaf Naturals LLC (United States)
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →